INT MEDICAL (01501) announced its financial results for the year ended December 31, 2025. The company recorded revenue of 1.065 billion yuan, representing a year-on-year increase of 25.06%. Gross profit reached 637 million yuan, up 18.44% compared to the previous year. Net profit amounted to 233 million yuan, a growth of 22.43%. Earnings per share were 1.26 yuan. The board proposed a dividend of 0.23 yuan per share.
According to the announcement, the increase in revenue was driven by a rise in new customers and business consolidation. During the reporting period, revenue from the sales of interventional medical devices was approximately 968 million yuan, an increase of about 25.17% compared to approximately 773 million yuan in the year ended December 31, 2024.
Comments